Charles River Laboratories International financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$724.22M $993.33M $1.06B $1.23B $1.30B $1.17B $1.13B $1.14B $1.13B $1.17B $1.30B $1.36B $1.68B $1.86B $2.27B $2.62B $2.92B $3.54B $3.98B $4.13B $0.00M
GM % Gross Margin %
39.87% 39.23% 38.42% 38.86% 38.51% 36.53% 34.91% 35.29% 35.13% 34.24% 36.68% 39.14% 39.14% 38.86% 37.19% 36.82% 36.90% 37.70% 36.79% 37.03% 0.00%
OM Operating Margin
21.81% 18.59% 17.78% 18.46% 19.26% 16.17% 12.94% 15.34% 15.55% 13.35% 14.79% 16.87% 16.24% 16.85% 15.10% 14.79% 15.59% 17.73% 16.56% 15.89% 0.00%
EPS Earnings Per Share
$2.29 $2.19 $2.62 $2.89 $2.38 $1.99 $2.56 $2.74 $2.93 $3.46 $3.76 $4.56 $5.27 $6.03 $6.73 $8.13 $10.32 $11.12 $10.60 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0
Sha. Shares
64.8m 72.3m 66.9m 67.92m 67.68m 65.9m 57.72m 49.44m 48.55m 48.12m 46.92m 46.62m 47.33m 47.36m 48.1m 48.84m 49.74m 50.46m 50.88m 51.3m 51.35m
OCF Operating Cash Flow
$184.83M $234.55M $164.37M $288.15M $282.73M $225.04M $169.01M $205.28M $207.90M $207.14M $251.05M $304.96M $314.84M $316.27M $437.41M $480.94M $546.58M $760.80M $619.64M $683.90M $0.00M
FCF Free Cash Flow
$140.09M $140.03M $-17.38M $57.21M $84.09M $145.19M $125.38M $157.70M $160.47M $167.99M $195.21M $223.11M $245.09M $235.64M $301.09M $340.42M $380.02M $532.03M $294.91M $346.49M $0.00M
FCFS Free Cash Flow Per Share
$2.82 $2.01 $-0.25 $0.85 $1.25 $2.22 $2.02 $3.07 $3.35 $3.52 $4.16 $5.20 $5.52 $4.92 $6.20 $6.99 $7.67 $10.58 $5.80 $7.13 $0.00